Positioning Ibd Therapies

Positioning IBD Therapies

State of the Art: Positioning Therapies in IBD

SCSG

Miguel Regueiro, MD | Positioning IBD Therapies

Gi Health Foundation

Positioning of Biologics and New Therapeutics for Crohn's Disease

The Evolving Therapeutic Paradigm in IBD: Optimal Positioning of New and Emerging Agents

Positioning current and future anti-integrin therapies for IBD

Should We Change How we Position Biologics for Use in Crohn’s Disease?

JAK Therapies: Mechanism of Action, Pharmacotherapeutic Profiles, and Positioning

Therapeutic Approaches to IBD in 2020 and Beyond

Positioning inhibitors of lymphocyte trafficking

Blum Center Program: The Management of Inflammatory Bowel Disease in 2023

MassGeneralHospital

Positioning of Biologics and New Therapeutics for Ulcerative Colitis

Comparative efficacy and positioning of IBD therapies today

Positioning anti-IL-12 and anti-IL-23 inhibitors

Positioning our recent and future advances in therapies for Crohn's disease

Positioning immunomodulators as monotherapies or in combination with biologics

Should We Change How We Position Biologics for Use in Ulcerative Colitis?

Tiny but Mighty: The New Small Molecules in IBD Treatment

Cleveland Clinic

Treating IBD: Biologics

Crohn's & Colitis Foundation

Positioning of Biologics in the Clinic